The progression of the COVID-19 pandemic has generated numerous emerging variants of
SARS-CoV-2 on a global scale. These variants have gained evolutionary advantages …

Since the outbreak of SARS-CoV-2, the etiologic agent of the COVID-19 pandemic, the viral
genome has acquired numerous mutations with the potential to alter the viral infectivity and …

Dear Editor The spike (S) protein is a homotrimer on the SARS‐CoV‐2 surface which targets
the angiotensin‐converting enzyme‐2 in humans (ACE2). The Spike (S) coronavirus 2 …

In this study, we report on the results of SARS-CoV-2 surveillance performed in an area of
Southern Italy for 12 months (from March 2021 to February 2022). To this study, we have …

The ongoing global pandemic of novel coronavirus pneumonia (COVID-19) caused by the
SARS-CoV-2 has a significant impact on global health and economy system. In this context …

Introduction The COVID‐19 vaccine was designed to provide protection against infection by
the severe respiratory coronavirus 2 (SARS‐CoV‐2) and coronavirus disease 2019 (COVID …

SARS-CoV-2 has continuously evolved as changes in the genetic code occur during
replication of the genome, with some of the mutations leading to higher transmission among …

The new coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) are causing health crisis of the world. To control the …

Аннотация Белки SARS CoV-2 представляют собой молекулы с массой от нескольких
десятков до нескольких тысяч аминокислотных остатков. Существуют структурные и …

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has triggered myriad efforts to
dissect and understand the structure and dynamics of this complex pathogen. The Spike …